For the first annual meeting, Select Biosciences says it has assembled a world class mixture of the best minds in this dynamic field
Over 200 attendees are expected and more than 15 exhibition booths will be presenting the latest technologies available.
To be held 26-27 September 2006 in Prague, this conference will provide a major networking opportunity and an unmissable event for those wishing to keep abreast of new developments in biomarker research.
Keynote presentations will include:.
Strategic considerations in biomarker discovery and development: Orest Hurko, VP translational research, Wyeth Research.
Biomarker reality check 2006: Klaus Lindpaintner, VP research and head, Roche Center for Medical Genomics.
The evolution of biomarkers: traditional indications, current applications and novel strategies: Peter Maimonis, VP, Biological R+D decision biomarkers:.Agenda sessions:.
Biomarker discovery.
Disease specific biomarkers.
Proteomics and expression signatures.
Biomarkers in genomics, metabolomics and translational medicine.
